Company Profile
Oncolytics Biotech Inc. Stock Price, News & Analysis
- Ticker:
- ONCY
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Canada and listed in the U
Stock performance
0.80 USD (+0.43%)
Close
Last updated: August 6, 2026
111M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, ONCY closed up 0.43% at $0.8006. No new same-company headline was identified in the current news window.
Company overview
Business overview
Oncolytics Biotech is an oncology company focused on oncolytic virus therapy and immune activation in cancer. Its story is built around using a viral platform to trigger stronger anti-tumor responses in difficult solid tumors.
Geographic Base and Sector Classification
Oncolytics is headquartered in Canada and listed in the U.S. market. It sits in small-cap oncology biotechnology.
Business Model Characteristics
The company depends on clinical validation, translational confidence, and capital support while it develops a narrow cancer platform. Investors usually watch efficacy, safety, and partnership interest.
Position Within the Biotechnology Landscape
Oncolytics occupies a specialized oncolytic-virus niche within biotech. The stock is catalyst-sensitive because the market still needs proof that the platform can create durable clinical value.
Future catalysts
Oncolytics’ catalysts are pelareorep and the oncology-combination program, where the next clinical update can materially move the stock. The company remains highly dependent on human data.
Recent news
- 01
Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer
Source: Oncolytics Biotech Inc.
- 02
- 03
Oncolytics Biotech® Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044
Source: Oncolytics Biotech Inc.
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Oncolytics Biotech Inc. (ONCY)?
Oncolytics Biotech Inc. (ONCY) most recently closed at 0.80 USD, a +0.43% move versus the previous session.
What is the market cap of Oncolytics Biotech Inc. (ONCY)?
Oncolytics Biotech Inc. currently has a market capitalization of 111M USD on BioPharmSignal.
What does Oncolytics Biotech Inc. do?
Oncolytics Biotech is an oncology company focused on oncolytic virus therapy and immune activation in cancer. Its story is built around using a viral platform to trigger stronger anti-tumor responses in difficult solid tumors.
On which exchange is ONCY stock listed?
Oncolytics Biotech Inc. (ONCY) is associated with NASDAQ, Canada and listed in the U, Biopharma.
What is Oncolytics?
Oncolytics’ catalysts are pelareorep and the oncology-combination program, where the next clinical update can materially move the stock.
Which conditions is Oncolytics Biotech Inc. targeting with Oncolytics?
Oncolytics Biotech Inc. is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Oncolytics Biotech Inc. describe recent progress with Oncolytics?
Oncolytics’ catalysts are pelareorep and the oncology-combination program, where the next clinical update can materially move the stock.
What is Biotech?
Oncolytics Biotech is an oncology company focused on oncolytic virus therapy and immune activation in cancer.